IL140630A0 - Isolated amphiphilic peptides derived from the cytoplasmic tail of viral envelope proteins - Google Patents

Isolated amphiphilic peptides derived from the cytoplasmic tail of viral envelope proteins

Info

Publication number
IL140630A0
IL140630A0 IL14063099A IL14063099A IL140630A0 IL 140630 A0 IL140630 A0 IL 140630A0 IL 14063099 A IL14063099 A IL 14063099A IL 14063099 A IL14063099 A IL 14063099A IL 140630 A0 IL140630 A0 IL 140630A0
Authority
IL
Israel
Prior art keywords
isolated
peptides derived
envelope proteins
cytoplasmic tail
viral envelope
Prior art date
Application number
IL14063099A
Original Assignee
Univ Southern California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Southern California filed Critical Univ Southern California
Publication of IL140630A0 publication Critical patent/IL140630A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13045—Special targeting system for viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/40—Vectors comprising a peptide as targeting moiety, e.g. a synthetic peptide, from undefined source

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL14063099A 1998-07-09 1999-07-08 Isolated amphiphilic peptides derived from the cytoplasmic tail of viral envelope proteins IL140630A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11254498A 1998-07-09 1998-07-09
PCT/IB1999/001261 WO2000002909A2 (en) 1998-07-09 1999-07-08 Amphiphilic peptides derived from the cytoplasmic tail of viral envelope proteins

Publications (1)

Publication Number Publication Date
IL140630A0 true IL140630A0 (en) 2002-02-10

Family

ID=22344479

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14063099A IL140630A0 (en) 1998-07-09 1999-07-08 Isolated amphiphilic peptides derived from the cytoplasmic tail of viral envelope proteins

Country Status (6)

Country Link
EP (1) EP1093519A2 (en)
JP (1) JP2003533165A (en)
AU (2) AU4386999A (en)
CA (1) CA2333855A1 (en)
IL (1) IL140630A0 (en)
WO (1) WO2000002909A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020064520A1 (en) * 1999-08-19 2002-05-30 Yanina Rozenberg Targeted artificial gene delivery
US7785903B2 (en) 2004-04-09 2010-08-31 Genentech, Inc. Variable domain library and uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2512792A (en) * 1991-08-30 1993-04-05 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Defective interfering hiv particles with chimeric cd4-env
EP0746625B1 (en) * 1992-11-09 2004-03-31 THE UNITED STATES GOVERNMENT as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Targetable vector particles
US5940307A (en) * 1994-12-14 1999-08-17 The Trustees Of Columbia University In The City Of New York Method for predicting the tendency of a protein to form amphiphilic αβ structure
AUPN861496A0 (en) * 1996-03-13 1996-04-04 Commonwealth Scientific And Industrial Research Organisation Lytic peptides

Also Published As

Publication number Publication date
JP2003533165A (en) 2003-11-11
AU2003235023A1 (en) 2003-09-11
AU4386999A (en) 2000-02-01
CA2333855A1 (en) 2000-01-20
EP1093519A2 (en) 2001-04-25
WO2000002909A2 (en) 2000-01-20
WO2000002909A3 (en) 2000-05-04

Similar Documents

Publication Publication Date Title
AU8828598A (en) Retrovirus and viral vectors
HUP0102478A3 (en) Particles of hcv envelope proteins: use for vaccination
AU6591998A (en) Viral vectors having chimeric envelope proteins containing the igg-binding domain of protein
AU3826899A (en) Peptide analogues of pacap
ZA9811316B (en) Novel hepatitis C virus NS5B protein
HUP0002472A3 (en) Isolated dendritic cell membrane protein genes
AU1606800A (en) Membrane transport proteins
AU3990799A (en) Viral characterization by direct detection of capsid proteins
HK1046911A1 (en) Stabilized viral envelope proteins and uses thereof
EP1100545A4 (en) Regulated expression of recombinant proteins using rna viruses
AU5652396A (en) Glucose-inducible recombinant viral vector
IL140630A0 (en) Isolated amphiphilic peptides derived from the cytoplasmic tail of viral envelope proteins
AU9105698A (en) Rab proteins
AU2241699A (en) Expression of proteolytically-sensitive peptides
AU4558799A (en) Methods and compositions for generating recombinant adeno-associated virus vectors
AU7471098A (en) Recombinant influenza viruses expressing tumor-associated antigens as antitum or agents
IL139016A0 (en) Retroviral vectors including modified envelope escort proteins
AU5563699A (en) Analogs of udp-murnac peptides, assays and kits
AU6301698A (en) Anti-hiv peptides and proteins
AU5681598A (en) Liposomes comprising peptide antigens derived from x protein of hepatitis b virus
AU1536999A (en) Modified sv40 viral vectors
FI973371A0 (en) An isolated peptide
ZA992569B (en) Separation of air.
GB9811171D0 (en) Viral vector
ZA200007318B (en) Particles of HCV envelope proteins: use for vaccination.